Michelle Dawson posts

Post published on Bluesky on 26 Nov 2023 10:44

Back to posts Previous post Next post
Bluesky Clinical trial clinicaltrials.gov Extract quoted in the post Question asked by Dawson in the post External link integrated into the post Autism terms
Open original post
View on Bluesky

1 integrated reply by Michelle Dawson

26 Nov 2023 10:48

Note: the secondary outcomes include "Change in Frith Happé Animations Task"--"The latency to look to the eye-region of faces relative to image onset, measured in milliseconds (ms) for sad and neutral faces and triangle pursuit duration in an anthropomorphic animated triangles test"?

View reply on Bluesky

Information about the link integrated into the post

Clinical trial

Yale University, American Academy of Child Adolescent Psychiatry. (2024). Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder. ClinicalTrials.gov. Yale University.

More information

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

Yale University, American Academy of Child Adolescent Psychiatry. (2024). Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder. ClinicalTrials.gov. Yale University.

Publication date
30 Apr 2024
Identifier
NCT06142955
Authors
Yale University, American Academy of Child Adolescent Psychiatry.
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
Yale University
Metadata source
clinicaltrials.gov

Abstract

This study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta Burst Stimulation (iTBS) session to provide preliminary insight into the potential of TMS as an intervention for depression in individuals with Autism Spectrum Disorder (ASD).

Open source Link to cited source